## 3 PDT in Veterinary Oncology
### Carcinomas
\begin{table}
\begin{tabular}{l l l l l l} \hline \hline
**Ref.** & **Neoplasm** & **Patients** & **PDT Protocol** & **Main Results** \\ \hline
[95] & \begin{tabular}{l} Transitional cell \\ carcinoma \\ \end{tabular} & 6 Dogs & \begin{tabular}{l} **PS:** 5-ALA, 60 mg/kg, oral \\ **Light:** Diode laser, 100 J/cm\({}^{-2}\), 635 nm, 1–3 sessions \\ \end{tabular} & \
\begin{tabular}{l} • \\ **Light:** Diode laser, 100 J/cm\({}^{-2}\), 635 nm, 1–3 sessions \\ \end{tabular} &
\begin{tabular}{l} • \\ **\(\bullet\)** \\ (pre-existing hydronephrosis) \\ \end{tabular} \\ \hline
[71] & \begin{tabular}{l} Transitional cell \\ carcinoma \\ \end{tabular} & 2 Dogs & \
\begin{tabular}{l} **PS:** 5-ALA, 40 mg/kg, oral \\ **Light:** LED, 300 J/cm\({}^{2}\), 635 nm, \\ 3 sessions; Diode laser, 270 J/cm\({}^{2}\), 630 nm, 15 sessions \\ \end{tabular} &
\begin{tabular}{l} • \\ **\(\bullet\)** \\ (270 J/cm\({}^{2}\), 635 nm, \\ \end{tabular} \\ \hline
[71] & \begin{tabular}{l} Adenocarcinoma \\ \end{tabular} & 2 Dogs & \
\begin{tabular}{l} **PS:** 5-ALA, 40 mg/kg, oral \\ **Light:** Diode laser, 270 J/cm\({}^{2}\), 700 J/cm, 630 nm, 15–19 sessions \\ \end{tabular} &
\begin{tabular}{l} • \\ **\(\bullet\)** \\ (270 J/cm\({}^{2}\), 630 nm, \\ \end{tabular} \\ \hline
[71] & \begin{tabular}{l} Sebaceous gland \\ carcinoma \\ \end{tabular} & 1 Cat & \
\begin{tabular}{l} **PS:** 5-ALA, 40 mg/kg, oral \\ **Light:** LED, 120 J/cm\({}^{2}\), 635 nm, \\ 4 sessions \\ \end{tabular} &
\begin{tabular}{l} • \\ **\(\bullet\)** \\ (270 J/cm\({}^{2}\), 635 nm, \\ \end{tabular} \\ \hline
[103] & \begin{tabular}{l} Transitional cell \\ carcinoma of the \\ prostate \\ \end{tabular} & 1 Dog & \
\begin{tabular}{l} **PS:** 5-ALA, 60 mg/kg \\ **Light:** Diode laser, 100 J/cm\({}^{2}\), 75 mW/cm\({}^{2}\), 635 nm, 1 session \\ \end{tabular} &
\begin{tabular}{l} • \\ **\(\bullet\)** \\ (270 J/cm\({}^{2}\), 635 nm, \\ \end{tabular} \\ \hline
[104] & \begin{tabular}{l} Prostate Carcinoma \\ \end{tabular} & 6 Dogs & \
\begin{tabular}{l} **PS:** 5-ALA, intratumoral \\ **Light:** Halogen lamp, 75 J/cm\({}^{2}\), 570-670 nm, 1 session \\ \end{tabular} &
\begin{tabular}{l} • \\ **\(\bullet\)** \\ (270 J/cm\({}^{2}\), 635 nm, \\ \end{tabular} \\ \hline
[105] & \begin{tabular}{l} SCC \\ \end{tabular} & 4 Dogs & \
\begin{tabular}{l} **PS:** BPD-MA, 0.5 mg/mg, iv \\ **Light:** Diode laser, 40–90 J/cm\({}^{2}\), 690 nm, 1 session \\ \end{tabular} &
\begin{tabular}{l} • \\ **\(\bullet\)** \\ (270 J/cm\({}^{2}\), 635 nm, \\ \end{tabular} \\ \hline
[106] & \begin{tabular}{l} SCC \\ \end{tabular} & 3 Dogs & \
\begin{tabular}{l} **PS:** BPD-MA, 0.5 mg/mg, iv \\ **Light:** Diode laser, 80–600 J/cm\({}^{2}\), 690 nm, 1–2 sessions \\ \end{tabular} &
\begin{tabular}{l} • \\ **\(\bullet\)** \\ (270 J/cm\({}^{2}\), \\ \end{tabular} \\ \hline
[107] & \begin{tabular}{l} Adenocarcinoma \\ \end{tabular} & 3 Dogs & \
\begin{tabular}{l} **PS:** BPD-MA, 0.5 mg/mg, iv \\ **Light:** Diode laser, 50–350 J/cm\({}^{2}\), 200–300 J/cm, 690 nm, 1–2 sessions \\ \end{tabular} &
\begin{tabular}{l} • \\ **\(\bullet\)** \\ (270 J/cm\({}^{2}\), 690 nm, 1–2 sessions \\ \end{tabular} \\ \hline
[108] & \begin{tabular}{l} Basal cell carcinoma \\ \end{tabular} & 1 Cat & \
\begin{tabular}{l} **PS:** PAD-S31, 15 mg/kg, iv \\ **Light:** Argon laser, 150 J/cm\({}^{2}\), 670 nm, 3 sessions \\ \end{tabular} &
\begin{tabular}{l} • \\ **\(\bullet\)** \\ (270 J/cm\({}^{2}\), \\ \end{tabular} \\ \hline
[109] & \begin{tabular}{l} Intranasal \\ carcinoma \\ \end{tabular} & 3 Dogs & \
\begin{tabular}{l} **PS:** Talaporfin sodium, \\ 5.0 mg/kg, iv \\ **Light:** Diode laser, 100 J/cm\({}^{2}\), 665 nm, 1–3 sessions \\ \end{tabular} &
\begin{tabular}{l} • \\ **\(\bullet\)** \\ (270 J/cm\({}^{2}\), \\ \end{tabular} \\ \hline
[96] & \begin{tabular}{l} SCC \\ \end{tabular} & 8 Cats & \
\begin{tabular}{l} **PS:** EtNBS, 5 mg/kg, iv \\ **Light:** Diode laser, 400–800 J/cm\({}^{2}\), 652 nm, 1–2 sessions \\ \end{tabular} &
\begin{tabular}{l} • \\ **\(\bullet\)** \\ (270 J/cm\({}^{2}\), \\ \end{tabular} \\ \hline
[96] & \begin{tabular}{l} SCC \\ \end{tabular} & 2 Dogs & \
\begin{tabular}{l} **PS:** EtNBS, 2.0–2.5 mg/kg, iv \\ **Light:** Diode laser, 303–400 J/cm\({}^{2}\), 652 nm, 1–2 sessions \\ \end{tabular} &
\begin{tabular}{l} • \\ **\(\bullet\)** \\ (270 J/cm\({}^{2}\), 635 nm, \\ \end{tabular} \\ \hline
[96] & \begin{tabular}{l} SCC \\ \end{tabular} & 2 Dogs & \
\begin{tabular}{l} **PS:** EtNBS, 2.0–2.5 mg/kg, iv \\ **Light:** Diode laser, 303–400 J/cm\({}^{2}\), 652 nm, 1–2 sessions \\ \end{tabular} &
\begin{tabular}{l} • \\ **\(\bullet\)** \\ (270 J/cm\({}^{2}\), 635 nm, \\ \end{tabular} \\ \hline \hline \end{tabular}
\end{table}